1. Machado R, Steinberg M, Bonds D, et al. (2005). Natriuretic peptide levels correlate with pulmonary pressures and prospective mortality in SCD: use of this biomarker to identify prevalence and mortality of pulmonary hypertension in the MSH cohort. Blood (ASH Annual Meeting Abstracts) 106: 1
2. Voskaridou E, Tsoutsias A, Tsetsos G, et al. (2006). The serum levels of N-terminal pro B-type natriuretic peptide (NT-proBNP) is a strong indicator of pulmonary hypertension in patients with sickle Cell/Beta thalassemia. Blood (ASH Annual Meeting Abstracts) 108: 1207
3. Chen CI, Delgado D, Munshi L, et al. (2005). Use of echocardiography in the diagnosis of cardiac AL Amyloidosis — an analysis of “presumed” and “endomyocardial biopsy-proven” disease. Blood (ASH Annual Meeting Abstracts) 106: 5085
4. Dispenzieri A, Lacy MQ, Hayman SR, et al. (2005). Powerful risk stratification in patients with AL using serum cardiac biomarkers. Blood (ASH Annual Meeting Abstracts) 106: 1162
5. Dispenzieri A, Lacy M, Zeldenrust S, et al. (2006). Cardiac biomarkers predict for ability to tolerate and complete therapy with Lenalidomide ± Dexamathosone in Al Amyloidosis. Blood (ASH Annual Meeting Abstracts) 108: 130